Meinian Onehealth Launches 'Meinian Good Doctor X Series' for Personalized Screening of Health Risks

Meinian Onehealth will launch its upgraded health management product, the Meinian Good Doctor X Series, on August 28, 2019. Focusing on single diseases and the eight major human body systems, this series provides personalized and targeted screening for health risks based on consumers’ diverse symptoms and health needs. It enables consumers to experience health checkups tailored to their individual conditions, comprehensive end-to-end health management, and worry-free health protection. Starting today, consumers can inquire about and purchase the service through Meinian Onehealth examination centers nationwide or via major e-commerce platforms.

Meinian Good Doctor X Series Launched

Meinian Onehealth has always been consumer-demand-oriented, striving for excellence in disease prevention. Building upon the “Meinian Good Doctor” product system launched in 2018—which offers comprehensive health management services including customized health checkups, Health Bank, personal physicians, direct medical access, and insurance coverage—Meinian Onehealth has taken a deep and meticulous approach to addressing major diseases with high prevalence among the Chinese population, such as cancers, cardiovascular and cerebrovascular diseases, diabetes, and the two major female cancers (breast and cervical cancer). In 2019, the company innovatively upgraded and launched the Meinian Good Doctor X Series, more effectively and focusedly tackling consumers’ health challenges of “lacking methods for early screening and having no clear direction for prevention,” by offering personalized and diverse health checkup packages for chronic disease management and cancer prevention.

Xu Ke, President of Meinian Onehealth, stated, “Against the backdrop of emphasizing whole-lifecycle health management, the Meinian Good Doctor X series focuses on screening for early symptoms and pathological changes associated with high-incidence diseases and specific conditions. This represents a further enhancement in disease screening, shifting from comprehensive to specialized and from broad to in-depth approaches. It enriches the substantive depth of current health checkup offerings and more effectively assists consumers in disease screening and prevention.”

Meinian Good Doctor X Series: Choose the health checkup services you need.

In designing its health checkup packages, Meinian Onehealth leverages annual health big data from nearly 30 million visits to focus on high-incidence diseases and develop the Meinian Good Doctor X series of package offerings. Within each package, screening methods for high-incidence diseases strictly adhere to the “gold standard” for disease diagnosis recognized by the clinical medical community, or use medical standards, industry guidelines, and expert consensus documents as the theoretical basis and quality benchmark for customizing screening items, thereby providing customers with authoritative and professional health checkup packages and examination methods.

As indicated in the "Chinese Guidelines for Low-Dose Spiral CT Screening of Lung Cancer" and the "Expert Consensus on the Clinical Application of Magnetically Controlled Capsule Gastroscopy in China," low-dose spiral CT and magnetically controlled capsule gastroscopy are effective methods for screening lung cancer and gastric diseases, respectively. Meinian Onehealth has incorporated these tests into the Meinian Good Doctor X Series screening packages as mandatory items, ensuring that customer screenings are conducted based on established evidence.

The newly launched Meinian Good Doctor X Series offers 15 customized health checkup packages across five series, ranging from six high-incidence single diseases—including lung cancer, diabetes, and cardiovascular disease—to the eight major human body systems. Designed to address diverse consumer health needs, these packages enhance the specificity and purposefulness of health screenings, providing timely early warnings and enabling more effective preventive care.

Triple Protection for Your Peace of Mind: Feel More Confident with Every Check-Up.

In addition to customizing packages based on the “gold standard” for disease diagnosis, the Meinian Good Doctor X Series provides consumers with multiple safeguards, enhances service quality, and alleviates concerns about health screenings. As a complimentary value-added service, “insurance coverage” offers greater protection for consumers undergoing examinations, reducing anxieties related to unexpected incidents during the screening process or the detection of serious diseases. Furthermore, while adhering to national standards for image acquisition feedback and physician interpretation and review, Meinian One Healthcare has established a specialized imaging re-review process, wherein professional physicians conduct a secondary assessment. By implementing a rigorous three-tiered protocol—“initial examination, secondary review, and tertiary verification”—the company ensures strict quality control at every stage, striving to deliver more accurate health screening results to consumers.

To ensure the accuracy and effectiveness of health screenings, advanced medical equipment serves as a powerful asset. Meinian Onehealth has consistently partnered with renowned domestic and international brands such as Philips, Siemens, and Roche to introduce cutting-edge equipment, ensuring that consumers receive high-value healthcare services.

Anticipating consumer needs and reflecting on their concerns, the launch of Meinian Good Doctor’s X Series has empowered consumers to achieve early screening and timely prevention of high-incidence diseases. Looking ahead, Meinian Health will continue to prioritize the health needs of the Chinese population, aim for accurate early disease detection, actively respond to the national “Healthy China” initiative, firmly uphold its corporate mission of “safeguarding the quality of life for every Chinese citizen,” and contribute greater strength to China’s medical and healthcare endeavors.

Meinian Onehealth Healthcare Industry (Group) Co., Ltd. was founded in 2004. As a professional health examination and medical services group in China, with its headquarters in Shanghai, it officially achieved nationwide coverage across mainland China (excluding Hong Kong, Macao, and Taiwan) in 2018. The company has established more than 400 specialized health examination centers throughout the country and employs a total of 40,000 staff members, including expert teams, medical and nursing personnel, and management professionals. It is a listed company with outstanding market capitalization and influence in the healthcare and broader health industry sectors.

Leveraging its vast customer base, massive health big data platform, and a standardized medical service network spanning across China, Meinian Onehealth has established a PDCA service closed loop encompassing professional examinations, risk assessment, health management, and medical security. It pioneered the implementation of a three-tier quality control system and a 36-hour report turnaround mechanism within the industry. Every step taken by Meinian Onehealth reflects its love and responsibility toward society and families, as it strives to build an influential health industry ecosystem in China and continues to lead the healthy and orderly development of the domestic medical services sector.